Table 2

Associations between RBM3 expression and clinicopathological characteristics.
RBM3 expression Negative (NS=0) Intermediate (NS=1-6) High(NS=9)
n(%) 77 (22.4) 213 (62.1) 53 (15.5) p-value
Age
≤ average 24 (31.2) 107 (50.2) 27 (50.9) 0.013
>average 53 (68.8) 106 (59.8) 26 (49.1)
Gender
Female 26 (33.8) 45 (21.1) 12 (22.6) 0.092
Male 51 (66.2) 168 (78.9) 41 (77.4)
T-stage
Ta 18 (23.4) 74 (34.7) 23 (43.4) <0.001
T1 15 (19.5) 77 (36.2) 24 (45.3)
T2-4 44 (57.1) 62 (29.1) 6 (11.3)
Grade
Low 8 (10.4%) 58 (27.2) 16 (30.2) 0.004
High 69 (89.6%) 155 (72.8) 37 (69.8)

Boman et al.

Boman et al. BMC Urology 2013 13:17   doi:10.1186/1471-2490-13-17

Open Data